The 7.3 million people in the UK aged between 60 and 69 are at increased risk of severe illness and death from COVID-19. Although the government’s age threshold for isolation is 70 years and over, data from countries such as China and Italy show that people aged 60-69 years are also at high risk of complications and death from COVID-19.
Writing in the Journal of the Royal Society of Medicine, Professor Azeem Majeed, Head of the Department of Primary Care & Public Health at Imperial College London, said that while this group is at a lower risk of severe illness when compared to those aged 70 years or older, their risk is still considerable.
Case fatality rates for those aged 60-69 are 3.5% in Italy and 3.6% in China. Other countries, including Switzerland and France, encourage those aged 65 and older to enforce strict public health measures due to their increased risk of severe illness and death from COVID-19.
Prof Majeed, who co-authored the paper with colleagues from Imperial College London and the University of Exeter, said: “The UK’s policy is at variance with the World Health Organisation, which states that those above the age of 60 years are at the highest risk, requiring additional preventative measures.”
“National and global spread of COVID-19 is accelerating. To reduce hospitalisations, intensive care admissions and death we recommend that those aged between 60 and 69 are particularly stringent when implementing public health measures such as social distancing and personal hygiene.”
The authors conclude: “In the absence of government guidance, people in this group can make their own informed decisions on how to minimise their risks of COVID-19 infection. This can include isolating themselves in a similar manner to that recommended by the UK government for people aged 70 years and over.”
Protecting older people from COVID-19: should the United Kingdom start at age 60? (DOI: 10.1177/0141076820921107) will be published by the Journal of the Royal Society of Medicine at 00:05 hrs (UK time) on Wednesday 22 April 2020.
The link for the full text version of the paper when published will be: https://journals.sagepub.com/doi/full/10.1177/0141076820921107
For further information or a copy of the paper please contact:
Media Office, Royal Society of Medicine
DL: +44 (0) 1580 764713
M: +44 (0) 7785 182732
The Journal of the Royal Society of Medicine (JRSM) is a leading voice in the UK and internationally for medicine and healthcare. Published continuously since 1809, JRSM features scholarly comment and clinical research. JRSM is editorially independent from the Royal Society of Medicine, and its editor is Dr Kamran Abbasi.
JRSM is a journal of the Royal Society of Medicine and it is published by SAGE Publishing.
Sara Miller McCune founded SAGE Publishing in 1965 to support the dissemination of usable knowledge and educate a global community. SAGE is a leading international provider of innovative, high-quality content publishing more than 1000 journals and over 800 new books each year, spanning a wide range of subject areas. A growing selection of library products includes archives, data, case studies and video. SAGE remains majority owned by our founder and after her lifetime will become owned by a charitable trust that secures the company’s continued independence. Principal offices are located in Los Angeles, London, New Delhi, Singapore, Washington DC and Melbourne. www.sagepublishing.com